ProfileGDS4718 / 224835_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 83% 90% 81% 81% 94% 89% 79% 79% 81% 81% 83% 81% 96% 87% 82% 75% 93% 94% 91% 82% 81% 76% 77% 82% 97% 79% 93% 85% 91% 85% 98% 87% 78% 87% 91% 86% 85% 83% 93% 77% 89% 97% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.3395875
GSM549102patient 115, normal, homogenized [OPG study]8.2076183
GSM549104patient 119, normal, homogenized [OPG study]9.1942390
GSM549108patient 138, normal, homogenized [OPG study]7.8597681
GSM549119patient 077, normal, homogenized [OPG study]7.9673181
GSM549133patient 032, cancer, homogenized [OPG study]10.114894
GSM549139patient 042, cancer, homogenized [OPG study]9.0583289
GSM549099patient 107, normal, homogenized [OPG study]7.6075679
GSM549109patient 139, normal, homogenized [OPG study]7.6919679
GSM549110patient 046, normal, homogenized [OPG study]7.8802981
GSM549114patient 063, normal, homogenized [OPG study]8.0026181
GSM549122patient 082, normal, homogenized [OPG study]8.1762183
GSM549134patient 033, cancer, homogenized [OPG study]7.9783481
GSM549136patient 036, cancer, homogenized [OPG study]10.567496
GSM549140patient 044, cancer, homogenized [OPG study]8.7333387
GSM549111patient 047, normal, homogenized [OPG study]8.1244682
GSM549113patient 057, normal, homogenized [OPG study]7.3555175
GSM549132patient 031, cancer, homogenized [OPG study]9.6200893
GSM549137patient 038, cancer, homogenized [OPG study]9.809294
GSM549142patient 047, cancer, homogenized [OPG study]8.8807791
GSM549100patient 110, normal, homogenized [OPG study]7.9543882
GSM549107patient 135, normal, homogenized [OPG study]7.9872281
GSM549115patient 068, normal, homogenized [OPG study]7.4866476
GSM549116patient 072, normal, homogenized [OPG study]7.6202277
GSM549120patient 078, normal, homogenized [OPG study]8.0888282
GSM549131patient 030, cancer, homogenized [OPG study]10.905397
GSM549118patient 074, normal, homogenized [OPG study]7.7420879
GSM549129patient 027, cancer, homogenized [OPG study]9.6847493
GSM549123patient 088, normal, homogenized [OPG study]8.4117885
GSM549124patient 006, cancer, homogenized [OPG study]9.150391
GSM549126patient 015, cancer, homogenized [OPG study]8.4950185
GSM549128patient 025, cancer, homogenized [OPG study]11.424898
GSM549103patient 117, normal, homogenized [OPG study]8.5829587
GSM549117patient 073, normal, homogenized [OPG study]7.6143478
GSM549138patient 041, cancer, homogenized [OPG study]8.7932387
GSM549141patient 045, cancer, homogenized [OPG study]9.5120391
GSM549130patient 028, cancer, homogenized [OPG study]8.5443686
GSM549101patient 111, normal, homogenized [OPG study]8.4132185
GSM549105patient 128, normal, homogenized [OPG study]8.121683
GSM549106patient 134, normal, homogenized [OPG study]9.8404693
GSM549112patient 048, normal, homogenized [OPG study]7.493577
GSM549125patient 011, cancer, homogenized [OPG study]8.9175789
GSM549127patient 024, cancer, homogenized [OPG study]10.691597
GSM549135patient 035, cancer, homogenized [OPG study]7.8547279